The Innovation Attorney Podcast
Executive Summary Mergers and acquisitions represent the primary liquidity mechanism for venture capital funded companies at a moment when the IPO window has remained narrow and portfolio company holding periods have stretched well beyond historical norms. In 2024, the United States recorded 995 VC-backed M&A transactions totaling $112.7 billion in disclosed value, and the first quarter of 2025 alone produced 205 deals worth $22.7 billion, signaling an acceleration driven by limited partner pressure for distributions and corporate buyers pursuing technology acquisition at a scale internal development cannot match. The fifteen subtopics in this report span the full arc of a VC-backed sale process: from initial enterprise value determination through purchase price mechanics, financial due diligence, corporate and intellectual property preparation, regulatory clearance, contractual consent requirements, representation and warranty frameworks, insurance structures, tax optimization, employment treatment, privacy and cybersecurity posture, contingent liability mapping, financing certainty, integration planning, and the deal certainty provisions governing the gap period between signing and closing. Several patterns emerge across the analysis. Information asymmetry between VC-backed sellers and corporate buyers has narrowed materially; sell-side quality of earnings reports, clean cap tables, and pre-corrected intellectual property assignment chains are now standard preparation steps in transactions above $50 million. Representations and warranties insurance has fundamentally altered indemnification economics, with premiums compressing to 2.5 to 4 percent of coverage limits and retentions falling below 1 percent of enterprise value in competitive processes. Regulatory risk from the Committee on Foreign Investment in the United States and antitrust authorities has extended deal timelines, forcing buyers to price the cost of delay into reverse termination fee structures. Post-closing integration remains the largest destroyer of deal value, with 60 to 70 percent of transactions failing to deliver projected synergies. For founders evaluating a sale process, the sequencing of preparation matters as much as the negotiation itself. Cap table clarity, intellectual property assignment chain integrity, material contract consent mapping, and privacy compliance posture all determine whether a sophisticated buyer proceeds at the agreed valuation or reopens pricing through a post-diligence retrade. The fifteen subtopics that follow provide the analytical foundation for every significant decision in a VC-backed M&A transaction. Detailed Findings Subtopic 1: Valuation and Purchase Price Methodology Enterprise value determination in VC-backed M&A transactions combines financial modeling, negotiation, and post-closing adjustment mechanisms that frequently shift the effective price by tens of millions of dollars from the headline number. Private SaaS companies in 2025 trade at median revenue multiples near 5.5 times, a compression from peak multiples above 15 times in 2021. For businesses meeting the Rule of 40 standard, where the sum of revenue growth rate and EBITDA margin equals at least 40 percent, valuations command a 50 to 100 percent premium over comparable companies that do not clear that threshold. Purchase price adjustments appear in more than 90 percent of private-target M&A transactions, and the median size of the related escrow increased to approximately 1 percent of transaction value in 2024. Disputes over working capital definitions represent a significant source of post-closing disputes. Net debt definitions extend beyond bank borrowings to include convertible notes not yet converted, deferred revenue representing a cash obligation, transaction bonuses, and unpaid taxes. Divergent net debt calculations routinely produce disagreements of 5 to 15 percent of enterprise value in technology transactions. Earnouts appeared in approximately one-third of 2024 private-target M&A transactions and serve as a valuation bridge when buyer and seller hold materially different views on future performance. Revenue-based earnout metrics are preferred by sellers because buyers have less discretion over expense allocation than over EBITDA. Rollover equity structures allow selling shareholders to defer tax while retaining upside in the acquiring entity. For investors managing liquidation preference stacks, the effective price at the company level and the return to any particular class of equity can diverge significantly depending on waterfall modeling. Subtopic 2: Quality of Earnings and Financial Due Diligence The gap between reported EBITDA and normalized buyer-tested EBITDA in a VC-backed company typically ranges from 10 to 25 percent of the reported figure once revenue recognition practices, customer concentration, one-time items, and executive add-backs are properly tested. Sellers who commissioned a sell-side quality of earnings report before going to market achieved TEV/EBITDA multiples of 7.4 times in 2024, compared with 7.0 times for sellers who did not, a differential that more than covers the cost of the report on any transaction above $30 million in enterprise value. Revenue recognition practices in VC-backed software companies are a frequent source of downward adjustments. Contracts recognized as revenue before all performance obligations are satisfied, arrangements with variable consideration not properly constrained, and multi-element arrangements that front-load revenue all attract buyer scrutiny. Customer concentration analysis examines whether any single customer represents more than 10 to 15 percent of revenue and whether that relationship is contractually protected or terminable at will. At least 90 percent of private equity-backed deals now employ sell-side quality of earnings analysis, and the practice has migrated into VC-backed strategic sale processes. The financial due diligence phase has grown in depth and duration; due diligence periods increased by 72 percent between 2022 and 2025. Buyers who identify material adjustments after the letter of intent is signed have contractual mechanisms to reopen price, and sophisticated sellers prepare quality of earnings reports precisely to reduce the probability of a post-LOI retrade. Subtopic 3: Legal and Corporate Due Diligence The corporate records of a VC-backed company reflect the accumulated complexity of multiple financing rounds, each of which introduced new economic rights, voting rights, and contractual obligations. Cap tables with multiple series of preferred stock, outstanding SAFEs, unconverted convertible notes, warrant coverage from bridge rounds, and option plan overhangs routinely contain errors or ambiguities that create signature blockers or indemnification exposure. Buyers require a fully reconciled capitalization table on a fully diluted, as-converted basis before proceeding to exclusivity. Stockholder consent requirements create potential deal delays. Protective provisions in preferred stock certificates of incorporation, drag-along rights in investor rights agreements, and co-sale agreements all require analysis to determine whether the proposed transaction triggers consent rights and whether those consents can be obtained on the required timeline. Minority stockholder protections can create negotiating leverage for individual stockholders at precisely the moment of closing. Buyers expect board meeting minutes that document major corporate decisions, complete records of stock issuances and transfers, and valid intellectual property assignment agreements for every founder and early employee. Companies that cannot produce these records face either deal delays while records are reconstructed or specific indemnification demands from buyers who price the risk of incomplete records into holdback structures. CVC-backed companies experience faster due diligence and higher close rates because buyers have access to institutional-quality records from the outset. Subtopic 4: Intellectual Property Ownership and Assignment Chain of title in intellectual property ownership is the factor that most often causes unexpected valuation adjustments or deal delays in technology M&A. The core question is whether the target company holds clear, unencumbered ownership of the intellectual property that constitutes the basis of its commercial value. Gaps arise most commonly from three sources: incomplete employee invention assignment agreements, contractor work product without written assignment, and open source software incorporated into commercial products under licenses that impose attribution or copyleft obligations on the acquirer. Best practice requires that employee assignment agreements contain presently effective assignment language that transfers intellectual property rights to the company immediately upon creation, without requiring any future execution of documents. Agreements that use language promising future assignment rather than present assignment create ambiguity about whether a court order would be required to perfect the transfer. Contractor agreements present a parallel risk because independent contractor work product does not qualify as a work-for-hire under United States copyright law for most categories of software. Open source software contamination is particularly acute in AI-related acquisitions, where rapid development pace means developers frequently incorporate libraries without tracking license obligations. Copyleft licenses, including versions 2 and 3 of the GNU General Public License, require that software distributed with the covered code also be released under the same terms. Pre-closing audits that map all open source components against their license obligations have become standard in technology M&A transactions above $25 million. Subtopic 5: Regulatory Approvals and Antitrust Clearance Regulatory approval risk in VC-backed M&A is not primarily about whether a transaction will be blocked; it is about how long clearance will take and what conditions will be imposed. The Hart-Scott-Rodino filing threshold increased to $126.4 million in 2025, with a further increase to $133.9 million effective in 2026. New HSR rules effective February 10, 2025 require substantially more substantive information at filing, including deal rationale narratives and documents provided to the supervisory deal team lead. CFIUS review has become a material consideration in any transaction involving a foreign acquirer of a VC-backed company with access to sensitive data, critical technologies, or critical infrastructure. Of 209 CFIUS notices reviewed in 2024, approximately 56 percent proceeded to the second 45-day investigation period, and 8 percent were approved subject to mitigation conditions. Mandatory filing requirements for covered TID US business transactions eliminate the option of proceeding without notification. Sector-specific regulatory approvals add time and conditionality risk beyond antitrust clearance. FDA approval requirements for medical device or pharmaceutical technology asset combinations require advance regulatory counsel coordination before signing. State insurance regulator approvals for InsurTech acquisitions add state-by-state complexity. Foreign direct investment regimes in the European Union, United Kingdom, Australia, and India have expanded in scope, meaning cross-border transactions may require parallel filings across multiple jurisdictions. Subtopic 6: Material Contracts and Change of Control Provisions Change-of-control clauses in customer agreements, key supplier contracts, intellectual property licenses, and real property leases can operate as closing conditions, as termination rights, or as consent requirements that give counterparties the opportunity to demand improved commercial terms as the price of their cooperation. A buyer who signs an acquisition agreement without mapping every such trigger has accepted an inventory of renegotiation leverage points held by counterparties who will learn about the transaction at a moment of maximum disruption. Anti-assignment provisions in commercial contracts require particular attention. Many technology agreements contain language that treats a change of beneficial ownership as a prohibited assignment even where the legal entity remains the same, making a stock acquisition subject to a consent requirement as well as an asset acquisition. Courts generally enforce these provisions and have held that consummation of a change of control without required consent constitutes a breach of contract. Experienced M&A counsel creates a consent matrix that identifies every material contract requiring consent or notice, the standard for obtaining consent, the likely position of each counterparty, and the consequence of failing to obtain consent. This matrix drives both the closing conditions negotiated with the buyer and the timeline for consent solicitation during the gap period. Subtopic 7: Representations, Warranties, and Indemnification Architecture The indemnification provisions of an M&A agreement are the operative allocation of financial risk between buyer and seller for a defined period after closing. General representations typically survive for 12 to 24 months post-closing and are subject to a cap ranging from 10 to 20 percent of the total purchase price. Fundamental representations covering due organization, valid authorization, capitalization, and title to assets typically survive for the applicable statute of limitations period. The distinction between fundamental and general representations matters enormously. A misrepresentation relating to the cap table, which is a fundamental representation, carries full purchase price exposure. A misrepresentation in the financial statements, a general representation, is subject to the capped recovery. A tipping basket means that once claims exceed the basket amount, typically 0.5 to 1 percent of purchase price, all losses from dollar one are recoverable. Representations and warranties insurance has largely displaced traditional seller indemnification for general representations in middle market and large transactions, meaning that the negotiation of basket and cap terms increasingly functions as the retention and policy limit determination for the RWI policy rather than as a direct negotiation of seller exposure. Sellers benefit from receiving full proceeds at closing. Buyers benefit from policy coverage available for the full survival period without dependence on individual selling shareholder financial wherewithal. Subtopic 8: Representations and Warranties Insurance Representations and warranties insurance has restructured the economics of private M&A indemnification and is now a standard feature of middle market and large transactions involving VC-backed companies. Premiums have compressed to 2.5 to 4 percent of the coverage limit, down from approximately 5 percent in early 2022, as carrier competition for market share has intensified. Coverage is now available for transactions as small as $25 million in enterprise value, with minimum premiums having declined materially. Retentions have fallen to 0.5 to 1 percent of enterprise value. The standard RWI policy provides three years of coverage for general representations and six years of coverage for fundamental representations, mirroring the survival periods in the underlying purchase agreement. The underwriting process involves detailed review of the due diligence record, the purchase agreement representations, and the disclosure schedules. Common exclusions include known matters disclosed in the disclosure schedules, forward-looking projections, pension liabilities, certain environmental conditions, and matters arising from the buyer own conduct. RWI is purchased on 20 to 30 percent of secondary-led deals in part to address the conflict-of-interest dynamics when a private equity sponsor needs a clean exit for its fund. For VC-backed companies, the RWI policy allows founders and investors to receive full proceeds at closing without holding back a material escrow. This structural shift from the pre-RWI standard, where sellers would hold 10 to 15 percent of proceeds in escrow for 18 to 24 months, represents a fundamental improvement in the economics of venture capital exits. Subtopic 9: Tax Structuring The decision between a stock deal and an asset deal, and the elections available to modify the tax treatment of each, can shift after-tax proceeds for VC investors and founders by more than the combined legal and advisory fees of the transaction. Asset deals generally provide buyers with a stepped-up tax basis in acquired assets. Stock deals preserve the existing tax basis but avoid the need to assign individual assets and obtain third-party consents, protecting the continuity of contracts containing anti-assignment clauses. The Section 338(h)(10) election allows parties to a stock acquisition of an S corporation or a subsidiary within a consolidated corporate group to treat the transaction as an asset sale for tax purposes while maintaining the legal simplicity of a stock purchase. Section 382 of the Internal Revenue Code limits the annual utilization of a target company net operating loss carryforwards following an ownership change, defined as an increase of more than 50 percentage points in ownership by five-percent shareholders over a rolling three-year period. Most VC-backed companies that have raised multiple institutional rounds will have experienced Section 382 ownership changes. The annual NOL limitation equals the equity value of the company multiplied by the applicable federal long-term tax-exempt rate at the time of the ownership change. A company with $100 million in net operating losses and an annual limitation of $3 million has an effective present value of those losses substantially below face value, a fact that buyers incorporate into enterprise value analysis. Subtopic 10: Employment, Compensation, and Benefits The workforce of a VC-backed company at the time of sale carries compensation obligations, equity treatment decisions, and regulatory exposure that routinely add 5 to 15 percent to transaction costs beyond the purchase price itself. Section 280G of the Internal Revenue Code imposes a 20 percent excise tax on excess parachute payments to disqualified individuals. The threshold for excess parachute treatment is three times the disqualified individual average taxable compensation over the prior five years. Private VC-backed companies have a structurally advantageous mechanism for managing Section 280G exposure that is not available to public companies. A stockholder vote by at least 75 percent of the shareholders eligible to vote prior to the change of control, excluding the disqualified individuals who would receive the excess parachute payments, can waive the excise tax consequences and restore the company tax deduction. This vote requires careful advance planning, independent legal analysis, and disclosure of the parachute payment amounts to stockholders before the vote. Equity award acceleration, whether single-trigger upon a change of control or double-trigger requiring both a change of control and a subsequent termination, is one of the largest components of transaction-related compensation. The Worker Adjustment and Retraining Notification Act requires 60 days advance written notice before mass layoffs or plant closings. Non-compete enforceability has become significantly more uncertain following Federal Trade Commission rulemaking activity and state-level restrictions in multiple jurisdictions. Subtopic 11: Data Privacy, Cybersecurity, and Information Security Posture A cybersecurity incident that occurred before closing but was not disclosed to the buyer is evidence of a representation breach that supports indemnification claims and, in egregious cases, fraud claims. Data about the target security posture, breach history, and regulatory compliance status has become a core component of M&A due diligence, with dedicated technical assessments conducted separately from traditional information technology reviews. The General Data Protection Regulation imposes fines of up to 4 percent of total worldwide annual turnover for material violations, and more than 1,878 fines totaling EUR 4.4 billion were imposed between May 2018 and October 2023. State privacy laws in California, Virginia, Colorado, Connecticut, Texas, and more than a dozen other states impose additional compliance obligations. VC-backed companies that have grown rapidly without proportionate investment in legal and compliance infrastructure frequently have gaps in data mapping, consent management, vendor agreements, and incident response documentation. The European Union Artificial Intelligence Act, which entered into force in August 2024 with phased implementation through 2026, imposes requirements on high-risk AI systems that extend beyond data privacy into algorithmic transparency, bias assessment, and human oversight mechanisms. VC-backed companies selling AI products into European markets face dual compliance obligations under both GDPR and the AI Act. Buyers who acquire these companies without assessing AI Act compliance exposure assume the associated remediation cost and potential regulatory liability. Subtopic 12: Litigation, Regulatory Investigations, and Contingent Liabilities The litigation section of a due diligence checklist reveals what the company adversaries think of its business practices, the quality of its contracts, and the strength of its intellectual property position. Pending litigation, threatened claims, government inquiries, and regulatory investigations represent contingent liabilities that buyers must price or protect against through the indemnification structure. The standard approach is to require sellers to represent that all material litigation is disclosed and to negotiate specific indemnification obligations for identified matters. Regulatory investigations require particular attention in VC-backed companies operating in regulated sectors. An FTC or DOJ civil investigative demand, an SEC subpoena, an FDA Warning Letter, or a state attorney general investigation may not have resulted in formal charges but nonetheless represents significant potential liability and management distraction. The disclosure obligation in the representations requires careful legal judgment about whether a given matter is threatened or merely an inquiry that may or may not develop into an adversarial proceeding. Environmental liabilities, while less common in software and technology companies, arise with meaningful frequency in companies that have hardware manufacturing operations, maintain physical research facilities, or have acquired assets from industrial predecessors. The liability standard under the Comprehensive Environmental Response, Compensation and Liability Act is strict, joint, and several, meaning that a buyer who acquires contaminated real property assumes cleanup liability regardless of fault. Subtopic 13: Financing Conditionality Whether a transaction has a financing condition is one of the most consequential structural decisions in an M&A negotiation and one that is often treated as a standard term rather than a fundamental allocation of execution risk. In a deal without a financing condition, the buyer is obligated to close regardless of whether debt financing is available. In a deal with a financing condition, the buyer may terminate the agreement if financing cannot be obtained, subject to whatever reverse termination fee has been agreed. The reverse termination fee, payable by the buyer to the seller if the buyer fails to close for specified reasons including financing failure, typically ranges from 2 to 7 percent of deal value in middle market transactions. The Alphabet acquisition of Wiz established a reverse termination fee near 10 percent of deal value, reflecting the regulatory risk premium associated with a large technology acquisition. The marketing period for high-yield debt, typically 20 to 25 consecutive business days, represents a minimum timeline between signing and closing. Specific performance provisions, which allow a seller to force the buyer to close when all conditions are satisfied and financing is available, have become increasingly prevalent in private equity-led acquisitions of VC-backed companies. Courts have enforced specific performance provisions as written. Sellers have also demanded provisions allowing them to specifically enforce the buyer obligation to use efforts to obtain debt financing, creating a powerful contractual remedy against buyers who attempt to escape a signed deal by allowing financing to fail. Subtopic 14: Integration Planning and Synergy Capture Between 60 and 70 percent of merging companies fail to deliver the projected cost savings or revenue synergies from a transaction, a failure rate that reflects the systematic underestimation of integration complexity at signing. The disconnect between deal thesis and integration reality arises from three consistent patterns: strategic rationale constructed around idealized operating assumptions, integration planning that begins too late, and cultural incompatibility treated as a soft problem rather than a structural one with measurable financial consequences. IT systems consolidation represents the most operationally complex integration challenge in technology acquisitions, with 68 percent of acquirers rating it as highly challenging and only 50 percent achieving complete system unification on the original timeline. Initial IT integration cost estimates regularly run 20 to 50 percent over budget. The consequence is not merely cost overrun but the maintenance of parallel systems that prevent the customer-facing product improvements and back-office efficiency gains that justified the acquisition premium. Customer retention planning is the integration activity most directly correlated with whether a VC-backed acquisition delivers its revenue projection. In subscription software businesses, customers who experience service disruption, product degradation, or key account manager turnover during the integration period churn at rates two to three times higher than the baseline churn embedded in the buyer synergy model. Acquirers who invest in dedicated customer success resources during the first 90 days post-closing and who retain sales personnel holding key customer relationships outperform those who accelerate integration timelines at the expense of customer continuity. Subtopic 15: Closing Conditions, Interim Operating Covenants, and Deal Certainty The period between signing and closing an M&A agreement is a legally structured interval during which both parties carry obligations, either party may face circumstances that affect the transaction, and the deal itself can be terminated, renegotiated, or litigated. The closing conditions, interim operating covenants, and termination provisions define the rights and obligations of both parties during this gap period and determine how much certainty a seller actually has that the deal will close on the agreed terms. Material adverse change clauses define the threshold below which a deterioration in the target business does not permit the buyer to walk away. A 2024 Commercial Court decision provided guidance that a reduction in equity value of 15 to 20 percent may be considered material and that a 20 percent reduction is material. Approximately 94 percent of United States public M&A deals executed between 2023 and 2025 included pandemic and epidemic carve-outs in the MAC definition. Ordinary course operating covenants restrict the target company ability to take material business actions between signing and closing without buyer consent. These covenants preserve the business the buyer agreed to purchase but can create friction for management teams that need to respond to competitive developments or customer demands in real time. Sellers who accept overly broad consent requirements risk operational paralysis during the gap period. Cross Cutting Themes Three themes connect the most critical subtopics. First, preparation quality on the sell side determines price retention more than negotiation skill; quality of earnings reports, cap table hygiene, and intellectual property assignment corrections all reduce the probability of post-LOI retrading. Second, representations and warranties insurance has restructured risk allocation across indemnification, escrow, and closing condition design simultaneously. Third, regulatory risk has migrated from a binary question of approval versus denial to a continuous variable of timeline and conditions, requiring buyers and sellers to price regulatory delay directly into termination fee structures and financing plans. A fourth connection links integration planning to valuation methodology: the earnout provisions, rollover equity structures, and retention packages that bridge valuation gaps at signing are only financially meaningful if the integration process is executed well enough for the target business to hit its post-closing performance targets. Parties who treat integration as a post-closing matter rather than a pre-signing planning exercise regularly find that the economic instruments designed to align their interests become instruments of litigation instead. Open Questions First: How will the expanded HSR information requirements affect deal timelines and the frequency of second requests, particularly for AI-related acquisitions where the competitive effect analysis requires novel economic frameworks? Second: Will the compression of RWI premiums and retentions continue as carrier competition intensifies, or will a period of elevated claims activity force a market correction in coverage pricing and underwriting standards? Third: How will the Federal Trade Commission evolving approach to non-compete enforceability affect retention package design and the practical certainty of key employee commitments between signing and closing? Fourth: As AI Act obligations take effect in the European Union through 2026, will US-based VC-backed companies with European operations face material valuation discounts from acquirers who price compliance remediation costs at the LOI stage? Fifth: Will the specific performance jurisprudence developed in high-profile litigation over failed acquisitions migrate from public company M&A into the VC-backed transaction context at a rate that effectively eliminates reverse termination fees as the buyer primary exit from a deal? Source List Primary Legal and Regulatory Sources: Hart-Scott-Rodino Antitrust Improvements Act of 1976, 15 U.S.C. Section 18a; Federal Trade Commission HSR threshold announcements for 2025 and 2026; Committee on Foreign Investment in the United States 2024 Annual Report; Internal Revenue Code Sections 280G, 338, 368, 382, and 336; Worker Adjustment and Retraining Notification Act, 29 U.S.C. Section 2101; EU General Data Protection Regulation 2016/679; EU Artificial Intelligence Act 2024/1689. Industry Data and Benchmarks: PitchBook-NVCA Venture Monitor Q4 2024 and Q4 2025; SRS Acquiom 2024 and 2025 M&A Deal Terms Studies; GF Data M&A Transactions Q4 2024 through Q2 2025; WTW Insurance Marketplace Realities 2025 RWI Update; CBIZ Representations and Warranties Insurance in 2025 M&A Analysis. Academic and Practitioner Research: BCG Post-Merger Integration Synergy Capture Analysis 2025; KPMG Venture Pulse Q4 2024 and Q4 2025; Houlihan Lokey 2024 Transaction Termination Fee Study; Fasken Key Takeaways from SRS Acquiom 2024 M&A Deal Terms Study; Harvard Law School Forum on M&A and Corporate Law M&A Analysis 2025. Trade Publications and Firm Alerts: Gibson Dunn IP Issues in M&A Deals; Gibson Dunn Data Privacy Issues in M&A Deals; White and Case HSR Final Rules Analysis; Skadden 2025 HSR Thresholds and Filing Fees; Morrison Foerster M&A in 2025 and Trends for 2026; AssuredPartners Evolving RWI Landscape 2025. General Web and Industry Sources: Crunchbase Global Venture Funding 2025 Analysis; SG Analytics US VC-Backed M&A in 2025; SaaS Capital 2025 Private SaaS Company Valuations; Bain and Company Looking Back at M&A in 2025. Bibliography BCG. Capturing Value from Synergy in PMI: Four Essential Steps. Boston Consulting Group, 2025. Bain and Company. Looking Back at M&A in 2025: Behind the Great Rebound. Bain and Company, 2026. CBIZ. Representations and Warranties Insurance in 2025 M&A: Trends and Best Practices. CBIZ, 2025. Cleary Gottlieb Steen and Hamilton. M&A 2025 in Review and a Look Ahead to 2026. Cleary Gottlieb, 2026. European Union. Regulation 2024/1689 on Artificial Intelligence. Official Journal of the European Union, July 2024. European Union. General Data Protection Regulation 2016/679. Official Journal of the European Union, May 2016. Fasken. Key Takeaways from SRS Acquiom 2024 M&A Deal Terms Study. Fasken, March 2025. Federal Trade Commission. New HSR Thresholds and Filing Fees for 2025. FTC Competition Matters, February 2025. Federal Trade Commission. Hart-Scott-Rodino Revised Thresholds 2026. Gibson Dunn Alert, 2026. Gibson Dunn and Crutcher. Top Intellectual Property Issues to Think About in M&A Deals. Gibson Dunn, 2024. Gibson Dunn and Crutcher. Top Data Privacy and Cybersecurity Issues to Think About in M&A Deals. Gibson Dunn, 2024. GF Data. M&A Transactions Report Q4 2024 through Q2 2025. GF Data Resources, 2025. Harvard Law School Forum on M&A and Corporate Law. The Art and Science of Earn-Outs in M&A. Harvard Law School, July 2025. Houlihan Lokey. 2024 Transaction Termination Fee Study. Houlihan Lokey, April 2025. KPMG. Venture Pulse Q4 2024 and Q4 2025: Global Analysis of Venture Funding. KPMG, 2025 and 2026. Morrison Foerster. M&A in 2025 and Trends for 2026. Morrison Foerster, January 2026. National Venture Capital Association and PitchBook. PitchBook-NVCA Venture Monitor Q4 2024. NVCA, January 2025. National Venture Capital Association and PitchBook. PitchBook-NVCA Venture Monitor Q4 2025. NVCA, January 2026. SaaS Capital. 2025 Private SaaS Company Valuations. SaaS Capital, 2025. SG Analytics. US VC-Backed M&A in 2025: Deals and Exits. SG Analytics, 2025. SRS Acquiom. M&A Deals: Key Trends from the 2025 Deal Terms Study. SRS Acquiom, 2025. WTW. Insurance Marketplace Realities 2025: Representations and Warranties Insurance. WTW, 2025. Interested in analysis about the intersection of venture capital, tech, artificial intelligence, public policy and the law? Check out my Substack channel. https://theinnovationattorney.substack.com/ This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit theinnovationattorney.substack.com/subscribe [https://theinnovationattorney.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_2]
24 episodes
Comments
0Be the first to comment
Sign up now and become a member of the The Innovation Attorney Podcast community!